Brilacidin had performed as well if not better that than the top antibiotic out there. All in a single dose with no SAEs. the value of such an antibiotic is huge and with a start of a phase 3 FDA approved trial the value of B will have easily double with the start of the next phase.
Prurisol will be partnered quickly for some easy cash, probably milestones... enough to keep the current trials going and even the new expected (and probably someunexpected) trials up running and moving!

Cellceutix has been doing and accomplishing eveything expected and even overreaching some expectations! although there is a very heavy sooty and distort in effect where paid bashers have attack every bit of news! Once this lawsuit is thrown out and the partner for P is announced the manipulators will be rolled over. Then we true investors put all our DD together and sue these manipulators! They are very easy to track even if they don't think so!